Tineke Riemens-Aarts
Utrecht, UT 3584CX, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline Gliomas.
Journal: International journal of molecular sciences
Published: December 18, 2024
Mapping T cell dynamics to molecular profiles through behavior-guided transcriptomics.
Journal: Nature protocols
Published: April 26, 2024
Uncovering the mode of action of engineered T cells in patient cancer organoids.
Journal: Nature biotechnology
Published: May 26, 2021
Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells.
Journal: Molecular therapy. Methods & clinical development
Published: November 23, 2020
Identification of a tumor-specific allo-HLA-restricted γδTCR.
Journal: Blood advances
Published: January 28, 2019
Evaluating in vivo efficacy - toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells.
Journal: Journal for immunotherapy of cancer
Published: August 17, 2018
Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance.
Journal: Haematologica
Published: May 07, 2016
Accessory cells of the microenvironment protect multiple myeloma from T-cell cytotoxicity through cell adhesion-mediated immune resistance.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 06, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026